Jonathan Graham

Currently holds a position at Amgen Inc

2.6

2.6

Position	Company	Period
Senior Vice President, General Counsel, Secretary	Amgen Inc	July 1, 2015 -
Senior Vice President, General Counsel	Danaher Corp	July 1, 2006 - Nov. 24, 2015

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-02-10	2025-02-07	Amgen Inc (AMGN)	S Sale	28,088 +6.8% 182.27 US$1,603,199	28,088 +6.8%	182.27	US$1,603,199
2025-02-07	2025-02-07	Amgen Inc (AMGN)	PrS Proposed sale	54,913 432.57 US$1,975,229	54,913	432.57	US$1,975,229
2023-11-13	2023-11-08	Amgen Inc (AMGN)	S Sale	94,574 -29.3% 399.87 US$3,609,135	94,574 -29.3%	399.87	US$3,609,135
2023-11-08	2023-11-08	Amgen Inc (AMGN)	PrS Proposed sale	10,000 272.83 US$2,728,300	10,000	272.83	US$2,728,300
2022-05-10	2022-05-10	Amgen Inc (AMGN)	S Sale	13,500 -26.6% 241.81 US$3,264,454	13,500 -26.6%	241.81	US$3,264,454
2021-02-05	2021-02-04	Amgen Inc (AMGN)	S Sale	11,110 -21.8% 236.51 US$2,627,625	11,110 -21.8%	236.51	US$2,627,625
2019-11-25	2019-11-22	Amgen Inc (AMGN)	S Sale	9,000 -17.4% 230.54 US$2,074,837	9,000 -17.4%	230.54	US$2,074,837